Biopsy Sciences LLC received approval to market its new Magne-Cath medical device to the European market, starting this quarter.
The Magne-Cath was developed to use in cardiovascular procedures to retrieve or manipulate objects during stent graft replacement, according to a written statement.
The device makes stent graft procedures faster and improves safety.
Clearwater-based Biopsy Sciences has requested but not yet received U.S. Food and Drug Administration approval to sell Magne-Cath in this…
↧